Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $6.4400 (-7.34%) ($6.4300 - $6.4400) on Thu. Feb. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.95% (three month average) | RSI | 57 | Latest Price | $6.4400(-7.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -4.1% a day on average for past five trading days. | Weekly Trend | CEMI declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) XLC(-36%) VXX(7%) UNG(-13%) XAR(-55%) SIL(-15%) | Factors Impacting CEMI price | CEMI will decline at least -2.475% in a week (0% probabilities). XRT(-20%) ICLN(-66%) IDRV(-32%) IPO(-75%) INDA(-54%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.475% (StdDev 4.95%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.05 | 5 Day Moving Average | $6.96(-7.47%) | 10 Day Moving Average | $7.33(-12.14%) | 20 Day Moving Average | $7.05(-8.65%) | To recent high | -18.8% | To recent low | 27.9% | Market Cap | $130m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |